Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) EPS (Weighted Average and Diluted): 2009-2025

Historic EPS (Weighted Average and Diluted) for Rockwell Medical (RMTI) over the last 13 years, with Sep 2025 value amounting to -$0.05.

  • Rockwell Medical's EPS (Weighted Average and Diluted) fell 225.00% to -$0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.18, marking a year-over-year decrease of 200.00%. This contributed to the annual value of -$0.03 for FY2024, which is 91.89% up from last year.
  • As of Q3 2025, Rockwell Medical's EPS (Weighted Average and Diluted) stood at -$0.05, which was down 0.00% from -$0.05 recorded in Q2 2025.
  • Rockwell Medical's EPS (Weighted Average and Diluted)'s 5-year high stood at $0.04 during Q3 2024, with a 5-year trough of -$1.04 in Q4 2021.
  • Its 3-year average for EPS (Weighted Average and Diluted) is -$0.05, with a median of -$0.05 in 2025.
  • In the last 5 years, Rockwell Medical's EPS (Weighted Average and Diluted) crashed by 1,055.56% in 2021 and then spiked by 157.14% in 2024.
  • Over the past 5 years, Rockwell Medical's EPS (Weighted Average and Diluted) (Quarterly) stood at -$1.04 in 2021, then surged by 95.19% to -$0.05 in 2022, then increased by 0.00% to -$0.05 in 2023, then increased by 20.00% to -$0.04 in 2024, then tumbled by 225.00% to -$0.05 in 2025.
  • Its last three reported values are -$0.05 in Q3 2025, -$0.05 for Q2 2025, and -$0.04 during Q1 2025.